STOCK TITAN

Hims & Hers (NYSE: HIMS) CFO exercises options, sells shares under trading plan

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) reported that Chief Financial Officer Oluyemi Okupe exercised stock options for 4,938 shares of Class A Common Stock at an exercise price of $5.0100 per share and on the same date sold 4,938 shares at a weighted average price of $29.9942 per share. The option exercise and related sale were effected under a Rule 10b5-1 trading plan adopted on May 21, 2025. Following the transactions, Okupe held 80,872 stock options directly and 7,853 shares of Class A Common Stock indirectly through the Oluyemi Okupe Separate Property Trust dated September 1, 2021.

Positive

  • None.

Negative

  • None.
Insider Okupe Oluyemi
Role Chief Financial Officer
Sold 4,938 shs ($148K)
Approx. gross sale proceeds $148K
Approx. exercise cost $25K
Approx. pre-tax spread $123K
Type Security Shares Price Value
Exercise Stock Option (right to buy) F1, F3 4,938 $0.00 $0.00
Exercise Class A Common Stock F1 4,938 $5.01 $25K
Sale Class A Common Stock F1, F2 4,938 $29.9942 $148K
holding Class A Common Stock -- -- --
Holdings After Transaction: Stock Option (right to buy) — 80,872 shares (Direct); Class A Common Stock — 264,117 shares (Direct); Class A Common Stock — 7,853 shares (Indirect, Held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021)
Footnotes (3)
  1. F1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.
  2. F2. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.95 - $30.0450. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  3. F3. 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.
Options exercised 4,938 shares Stock options exercised into Class A Common Stock on August 19, 2026
Exercise price $5.0100 per share Exercise price of stock options exercised on August 19, 2026
Shares sold 4,938 shares Class A Common Stock sold on August 19, 2026
Weighted average sale price $29.9942 per share Weighted average price of shares sold, within $29.95–$30.0450 range
Options held after transaction 80,872 options Total stock options held directly by Oluyemi Okupe after exercise
Indirect shares held 7,853 shares Class A Common Stock held indirectly via Separate Property Trust
Rule 10b5-1 plan adoption date May 21, 2025 Trading plan governing reported exercises and sales
Vesting commencement date January 24, 2022 Start date for option vesting schedule described in footnote
Rule 10b5-1 trading plan regulatory
"stock option exercises and sales ... were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"Price reported constitutes the average weighted price of shares sold."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Vesting Commencement Date financial
"twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022."
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
monthly installments financial
"vest in a series of thirty-six (36) successive equal monthly installments"
Monthly installments are regular, fixed payments made each month to gradually pay off a larger amount, such as a loan or purchase. Think of it like paying for a big item in small, manageable parts instead of all at once. For investors, understanding installment payments helps gauge how debts are structured and how they might affect financial stability or cash flow over time.

FAQ

What insider transaction did HIMS CFO Oluyemi Okupe report on this Form 4?

Oluyemi Okupe reported exercising 4,938 stock options for Class A Common Stock at $5.0100 per share and selling 4,938 shares of Class A Common Stock at a weighted average price of $29.9942 per share, all on August 19, 2026.

Was the August 19, 2026 HIMS insider sale by the CFO under a Rule 10b5-1 plan?

Yes. The filing states the stock option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by Oluyemi Okupe.

What prices were involved in the HIMS CFO’s August 19, 2026 transactions?

The options were exercised at an exercise price of $5.0100 per share. The 4,938 shares of Class A Common Stock sold had a weighted average sale price of $29.9942 per share, with individual sale prices ranging from $29.95 to $30.0450.

How many HIMS stock options does the CFO hold after these transactions?

After the reported option exercise, Oluyemi Okupe held 80,872 stock options directly, as shown by the total options following the derivative transaction entry.

What indirect HIMS share holdings does the CFO report?

The filing shows an indirect holding of 7,853 shares of Class A Common Stock, held by the Oluyemi Okupe Separate Property Trust dated September 1, 2021.

What is the vesting schedule for the HIMS stock options referenced in the Form 4?

The filing explains that 25% of the options vest on the 12-month anniversary of the January 24, 2022 Vesting Commencement Date, and the remaining options vest in 36 equal monthly installments, subject to continuous service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Okupe Oluyemi

(Last)(First)(Middle)
2269 CHESTNUT STREET, #523

(Street)
SAN FRANCISCO CALIFORNIA 94123

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/19/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock08/19/2026M(1)4,938A$5.01269,055D
Class A Common Stock08/19/2026S(1)4,938D$29.9942(2)264,117D
Class A Common Stock7,853IHeld by Oluyemi Okupe Separate Property Trust dtd 9-1-2021
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$5.0108/19/2026M(1)4,938 (3)02/23/2032Class A Common Stock4,938$080,872D
Explanation of Responses:
1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.
2. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.95 - $30.0450. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
3. 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.
Remarks:
/s/ Kimberly Mather, Attorney-in-Fact for Oluyemi Okupe08/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)